Medicare Part D

Medicare Part D. It is the federal program providing subsidized prescription drug coverage to individuals enrolled in Medicare (United States). Established by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 and launched in 2006, it is administered by private insurance companies and pharmacy benefit managers under contract with the Centers for Medicare & Medicaid Services. The program aims to reduce out-of-pocket costs for medications for senior citizens and certain younger people with disabilities.

Overview

The program was a major expansion of the Medicare (United States) system, representing the largest overhaul since the creation of Medicare Part B in 1965. Its creation followed years of legislative debate, including proposals from the Clinton administration and the National Bipartisan Commission on the Future of Medicare. Key architects of the final legislation included Bill Thomas, then-Chairman of the House Ways and Means Committee, and Senate Majority Leader Bill Frist. The program's implementation was overseen by the Centers for Medicare & Medicaid Services under the Department of Health and Human Services.

Eligibility and enrollment

Eligibility is automatic for anyone entitled to benefits under Medicare Part A or enrolled in Medicare Part B. This includes individuals aged 65 and older, as well as younger people receiving Social Security Disability Insurance benefits after a 24-month waiting period. Individuals with End-stage renal disease or Amyotrophic lateral sclerosis are also eligible. Enrollment is voluntary and occurs during an initial enrollment period surrounding one's 65th birthday, with annual open enrollment periods typically occurring in the fall. Beneficiaries may face a late enrollment penalty if they go without creditable coverage from an employer-sponsored plan or Veterans Health Administration for a continuous period.

Plan structure and coverage

Coverage is provided exclusively through private plans approved by the Centers for Medicare & Medicaid Services. These include Stand-alone prescription drug plans that work alongside Original Medicare and Medicare Advantage plans that integrate medical and drug benefits. All plans must offer a standard benefit design or one of actuarially equivalent value. Each plan establishes its own formulary, or list of covered drugs, which is developed with input from pharmacy and therapeutics committees. Formularies typically categorize drugs into tiers, with different copayment amounts. Plans must cover drugs from all therapeutic categories and include at least two drugs in most classes.

Costs to beneficiaries

Beneficiaries typically pay a monthly premium, which varies significantly by plan and geographic region, with national average premiums reported annually by the Centers for Medicare & Medicaid Services. Additional costs include an annual deductible, coinsurance, and copayment amounts that apply during the initial coverage phase. Those with higher incomes, as defined by the Internal Revenue Service, pay an income-related monthly adjustment amount in addition to their plan premium. Many beneficiaries receive low-income subsidy assistance, also known as Extra Help, which is administered by the Social Security Administration and can dramatically reduce out-of-pocket costs.

The coverage gap ("donut hole")

The term refers to a temporary limit on what the plan will cover for drugs, a feature of the standard benefit design from 2006 until 2019. In this phase, beneficiaries were responsible for a higher percentage of their drug costs. The Affordable Care Act, signed by President Barack Obama, included provisions to gradually close this gap by 2020. The closure was achieved through a combination of manufacturer discounts and increased plan contributions, a process overseen by the Centers for Medicare & Medicaid Services. The Bipartisan Budget Act of 2018 accelerated the closure timeline by one year.

Administration and regulation

The Centers for Medicare & Medicaid Services, an agency within the Department of Health and Human Services, has overall regulatory authority. Day-to-day operations and beneficiary customer service are handled by contracted private entities, including insurance companies like UnitedHealth Group and CVS Health, and pharmacy benefit managers such as Express Scripts. The program is subject to oversight by the United States Congress, particularly the Senate Finance Committee and the House Committee on Energy and Commerce. Program performance and spending are frequently analyzed by the Medicare Payment Advisory Commission and the Congressional Budget Office. Category:Medicare (United States) Category:Health insurance in the United States Category:2003 in American law